105 related articles for article (PubMed ID: 23552705)
1. Galantamine-associated nightmares and anxiety.
Corbo JM; Brown JN; Moss JM
Consult Pharm; 2013 Apr; 28(4):243-6. PubMed ID: 23552705
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
Isik AT; Bozoglu E; Naharci MI; Kilic S
Am J Geriatr Pharmacother; 2010 Oct; 8(5):454-9. PubMed ID: 21335298
[TBL] [Abstract][Full Text] [Related]
3. One-week dose titration of extended release galantamine in patients with Alzheimer's disease.
Scharre DW; Shiovitz T; Zhu Y; Amatniek J
Alzheimers Dement; 2008 Jan; 4(1):30-7. PubMed ID: 18631948
[TBL] [Abstract][Full Text] [Related]
4. A case report of paranoid delusion with galantamine use.
Iraqi A; Hughes TL
J Am Geriatr Soc; 2005 Nov; 53(11):2036-7. PubMed ID: 16274397
[No Abstract] [Full Text] [Related]
5. Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease.
Stahl SM; Markowitz JS; Papadopoulos G; Sadik K
Curr Med Res Opin; 2004 Apr; 20(4):517-24. PubMed ID: 15119989
[TBL] [Abstract][Full Text] [Related]
6. Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study.
Dunbar F; Zhu Y; Brashear HR
Clin Ther; 2006 Mar; 28(3):365-72. PubMed ID: 16750451
[TBL] [Abstract][Full Text] [Related]
7. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.
Prescrire Int; 2001 Dec; 10(56):180-1. PubMed ID: 11824442
[TBL] [Abstract][Full Text] [Related]
8. Two galantamine titration regimens in patients switched from donepezil.
Engedal K; Davis B; Richarz U; Han J; Schäuble B; Andreasen N
Acta Neurol Scand; 2012 Jul; 126(1):37-44. PubMed ID: 21992111
[TBL] [Abstract][Full Text] [Related]
9. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.
Brodaty H; Corey-Bloom J; Potocnik FC; Truyen L; Gold M; Damaraju CR
Dement Geriatr Cogn Disord; 2005; 20(2-3):120-32. PubMed ID: 15990426
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
Schwalbe O; Wunderlich S; Kloft C
Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
[TBL] [Abstract][Full Text] [Related]
12. An unusual case of nightmares with galantamine.
Iraqi A; Hughes TL
J Am Geriatr Soc; 2009 Mar; 57(3):565. PubMed ID: 19278402
[No Abstract] [Full Text] [Related]
13. The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.
Chankrachang S; Senanarong V; Poungvarin N; Phanthumchinda K; Tavichachart N; Praditsuwan R; Nidhinandana S
J Med Assoc Thai; 2008 Sep; 91(9):1343-9. PubMed ID: 18843862
[TBL] [Abstract][Full Text] [Related]
14. [Complete atrioventricular block during galantamine therapy].
Leentjens AF; Kragten JA
Ned Tijdschr Geneeskd; 2006 Mar; 150(10):563-6. PubMed ID: 16566422
[TBL] [Abstract][Full Text] [Related]
15. Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population.
Van Puyvelde K; Mets T;
Geriatr Gerontol Int; 2011 Jul; 11(3):256-61. PubMed ID: 21199235
[TBL] [Abstract][Full Text] [Related]
16. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
Cossu G; Melis M; Melis G; Maccioni E; Putzu V; Catte O; Putzu PF
Mov Disord; 2004 Oct; 19(10):1243-4. PubMed ID: 15389998
[TBL] [Abstract][Full Text] [Related]
17. [Complete atrioventricular block during galantamine therapy].
Schölzel-Dorenbos CJ
Ned Tijdschr Geneeskd; 2006 Apr; 150(17):989-90; author reply 990. PubMed ID: 17225744
[No Abstract] [Full Text] [Related]
18. [Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease].
Blesa R; García Ribas G; Galdós L; Olascoaga J; Amer G; Marey López J; Barquero M; Marsall C; Ezpeleta D
Neurologia; 2006; 21(6):289-96. PubMed ID: 16799903
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.
López-Pousa S; Olmo JG; Franch JV; Estrada AT; Cors OS; Nierga IP; Gelada-Batlle E
Age Ageing; 2006 Jul; 35(4):365-71. PubMed ID: 16788079
[TBL] [Abstract][Full Text] [Related]
20. Acute cholinergic syndrome in a patient with Alzheimer's disease taking the prescribed dose of galantamine.
Hanazawa T; Kamijo Y; Yoshizawa T; Fujita Y; Usui K; Haga Y
Psychogeriatrics; 2018 Sep; 18(5):434-435. PubMed ID: 29993163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
